KL-6 treatment also resulted in the downregulation of Bcl-2 and MCL1, two genes that suppress apoptosis, suggesting that KL-6 triggers apoptosis in pancreatic cancer cells. This evidence concerns the gene MUC1 and familial pancreatic carcinoma.